OncoSec Medical proclaims preliminary clinical observations of OMS-1140 Clinical Trial of ImmunoPulse in TNBC patients Read more
Ligand Pharmaceuticals initiates a program to develop contrast agents for Diagnostic Imaging Read more
Pandion Therapeutics sought $58 million Series A funding to advance drug programs for autoimmune and inflammatory diseases Read more
Relmada Therapeutics obtained global rights to market dextromethadone for treating CNS diseases Read more
Eiger Biopharmaceuticals disappointed over negative results of Phase 2 LIBERTY study in PAH Read more
Marina Biotech enters into agreement with Autotelic Bio for developing Marina’s IT-103 Clinical program Read more